期刊文献+

分析及预测治愈艾滋病的策略

Strategies for human immunodeficiency virus cure:current status and future prospects
下载PDF
导出
摘要 抗反转录病毒联合疗法(cART)虽然能控制艾滋病病程,延长患者生命,但需长期用药,停药后会出现人类免疫缺陷病毒(HIV)反弹。体内HIV潜伏库细胞是造成病毒反弹的主要因素,围绕该潜伏库的研究发展出了多种艾滋病治愈的概念和策略。本文聚焦当前国际前沿,介绍一些具有重要发展前景的艾滋病治愈策略,并预测其未来的发展方向。 The combined antiretroviral therapy (cART) has been applied to control the course of human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS). However, cART requires life-long daily treatment and strict adherence. HIV can quickly rebound after drug withdrawal because of the presence of the latent HIV reservoir in vivo. Therefore, reactivation of latent HIV and elimination of latent HIV reservoir are critical for cure of HIV infection and AIDS. Here, we review the recent advancements and future prospects on the strategies for HIV cure.
出处 《微生物与感染》 2015年第5期264-274,共11页 Journal of Microbes and Infections
基金 国家自然科学基金(81361120378 81373456)
关键词 人类免疫缺陷病毒 治愈 潜伏库 激活加清除 基因治疗 治疗性疫苗 Human immunodeficiency virus Cure Latent reservoir Shock and kill Gene therapy Therapeutic vaccine
  • 相关文献

参考文献72

  • 1Panel on Antiretroviral Guidelines for Adults, Adolescents.Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents [EB/OL]. http://aidsinfo.nih. gov/contentfiles/lvguidelines/glchunk/glchunk_14. pdf.
  • 2Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIVinfection as a chronic disease [J]. Lancet, 2013, 382(993):1525-1533.
  • 3Chun TW, Justement JS, Murray D, Hallahan CW, MaenzaJ,Collier AC, Sheth PM, Kaul R, Ostrowski M, Moir S,Kovacs C,Fauci AS. Rebound of plasma viremia followingcessation of antiretroviral therapy despite profoundly lowlevels of HIV reservoir: implications for eradication [J].AIDS, 2010,24(18): 2803-2808.
  • 4Lake JE,Currier JS. Metabolic disease in HIV infection[J]. Lancet Infect Dis, 2013,13(11): 964-975.
  • 5Clifford DB,Ances BM. HIV-associated neurocognitivedisorder [J]. Lancet Infect Dis, 2013,13(11) : 976-986.
  • 6Chun TW, Engel D, Berrey MM,Shea T,Corey L,FauciAS. Early establishment of a pool of latently infected?resting CD4+ T cells during primary HIV-1 infection [J].Proc Natl Acad Sci USA, 1998,95(15) : 8869-8873.
  • 7Chun TW, Carruth L,Finzi D, Shen XF, DiGiuseppe JA,Hermankova M,Chadwick K, MargolickJ, Quinn TC,KuoYH, Brookmeyer R, Zeiger MA, BarditchCrovo PA.Quantification of latent tissue reservoirs and total body viralload in HIV-1 infection [J]. Nature, 1997, 387 ?6629):183-188.
  • 8Wagner TA, McKernan JL, Tobin NH, Tapia KA, MullinsJI,Frenkel LM. An increasing proportion of monotypicHIV-1 DNA sequences during antiretroviral treatmentsuggests proliferation of HIV-infected cells [J]. J Virol,2013, 87(3): 1770-1778.
  • 9Finzi D, BlanksonJ,Siliciano JD, Margolick JB, ChadwickK,Pierson T,Smith K, Lisziewicz J, Lori F, Flexner C,Quinn TC, Chaisson RE, Rosenberg E, Walker B,GangeS, Gallant J, Siliciano RF. Latent infection of CD4+ T cellsprovides a mechanism for lifelong persistence of HIV-1,even in patients on effective combination therapy [J]. NatMed, 1999,5(5): 512-517.
  • 10Hiitter G,Nowak D,Mossner M,Ganepola S, Miissig A,Allers K,Schneider T, Hofmann J, Kiicherer C, Blau O,Blau IW,Hofmann WK,Thiel E. Long-term control ofHIV by CCR5 Delta32/Delta32 stem-cell transplantation[J]. N Engl J Med, 2009, 360(7): 692-698.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部